Contact
searchSearch
HMP Global

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

May-16

Managing Mental Health: Tackling Schizophrenia Head On
05/17/2016
Managing Mental Health is a 3-part series dedicated to exploring the challenges managed care professionals face regarding the treatment of mental health illnesses, with a specific focus on dementia, schizophrenia, and depression.
Managing Mental Health is a 3-part series dedicated to exploring the challenges managed care professionals face regarding the treatment of mental health illnesses, with a specific focus on dementia, schizophrenia, and depression.
Managing Mental Health is a...
05/17/2016
First Report Managed Care
Department
Newer Insulin Therapy Options Broaden Treatment
05/17/2016
As the prevalence of diabetes grows, so does the number of insulin products on the market.
As the prevalence of diabetes grows, so does the number of insulin products on the market.
As the prevalence of diabetes...
05/17/2016
First Report Managed Care
Biosimilars: Looking to Europe
05/17/2016
At a recent AMCP industry workshop, experts highlighted the need to look to the European market experience with biosimilars.
At a recent AMCP industry workshop, experts highlighted the need to look to the European market experience with biosimilars.
At a recent AMCP industry...
05/17/2016
First Report Managed Care
The Burden of Idiopathic Pulmonary Fibrosis
05/17/2016
Effects of forced vital capacity decline and suspected early acute idiopathic pulmonary fibrosis exacerbation on utilization and outcomes were recently discussed.
Effects of forced vital capacity decline and suspected early acute idiopathic pulmonary fibrosis exacerbation on utilization and outcomes were recently discussed.
Effects of forced vital capacity...
05/17/2016
First Report Managed Care
Department
Tofacitinib After One TNF Inhibitor Cost-Effective for RA, Study Finds
05/17/2016
A treatment strategy with Xeljanz (tofacitinib) after one tumor necrosis factor inhibitor for RA is more cost-effective than tofacitinib following 2 TNF inhibitors.
A treatment strategy with Xeljanz (tofacitinib) after one tumor necrosis factor inhibitor for RA is more cost-effective than tofacitinib following 2 TNF inhibitors.
A treatment strategy with...
05/17/2016
First Report Managed Care
Department
Alemtuzumab Shows Cost Savings in 5-Year Treatment Scenario
05/17/2016
Treatment with alemtuzumab (Lemtrada, Genzyme) for relapsing-remitting multiple sclerosis (RRMS) demonstrated a cost savings compared with subcutaneous interferonß-1a due to cost avoidance in relapse reduction and drug cost associated with...
Treatment with alemtuzumab (Lemtrada, Genzyme) for relapsing-remitting multiple sclerosis (RRMS) demonstrated a cost savings compared with subcutaneous interferonß-1a due to cost avoidance in relapse reduction and drug cost associated with...
Treatment with alemtuzumab...
05/17/2016
First Report Managed Care
Department
Formulary Frontlines: Challenges of Pain Management
05/17/2016
A Crippling Burden for US Stakeholders
A Crippling Burden for US Stakeholders
A Crippling Burden for US...
05/17/2016
First Report Managed Care
Direct to Consumer Advertising: Higher Cost Treatments or Better Informed Consumers?
05/17/2016
The AMA wants to ban Direct to Consumer (DTC) advertising of prescription drugs and medical devices. Our expert pannel offer their take on whether DTC ads lead to higher cost or more informed patients.
The AMA wants to ban Direct to Consumer (DTC) advertising of prescription drugs and medical devices. Our expert pannel offer their take on whether DTC ads lead to higher cost or more informed patients.
The AMA wants to ban Direct to...
05/17/2016
First Report Managed Care
CMS Final Rule on Medicaid Managed Care Programs
05/17/2016
On Monday, April 25, 2016, the Centers for Medicare & Medicaid Services (CMS) released its final rule updating managed care in Medicaid and the Children’s Health Insurance Program (CHIP). Overall, nearly 900 individuals and organizations...
On Monday, April 25, 2016, the Centers for Medicare & Medicaid Services (CMS) released its final rule updating managed care in Medicaid and the Children’s Health Insurance Program (CHIP). Overall, nearly 900 individuals and organizations...
On Monday, April 25, 2016, the...
05/17/2016
Population Health

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

News
Report: Amazon Likely to Partner With Large PBM
08/15/2017
After early rumors surfaced that Amazon was looking to move into the pharmacy distribution business, a recent report from Goldman Sachs suggests that the giant retailer will likely partner with a large pharmacy benefit manager.
After early rumors surfaced that Amazon was looking to move into the pharmacy distribution business, a recent report from Goldman Sachs suggests that the giant retailer will likely partner with a large pharmacy benefit manager.
After early rumors surfaced that...
08/15/2017
First Report Managed Care
News
Comparing Radiation Treatments for Managing Localized, Intermediate-Risk Prostate Cancer
04/01/2021
A recent study comparing brachytherapy, dose-escalated external beam radiotherapy, and stereotactic body radiation therapy for intermediate-risk localized prostate cancer, suggests that brachytherapy is the most appropriate management...
A recent study comparing brachytherapy, dose-escalated external beam radiotherapy, and stereotactic body radiation therapy for intermediate-risk localized prostate cancer, suggests that brachytherapy is the most appropriate management...
A recent study comparing...
04/01/2021
Journal of Clinical Pathways
Dabigatran to Treat Patients with Acute Venous Thromboembolism
02/19/2014
New Orleans—A prespecified subgroup analysis of 2 randomized, phase 3 trials that included patients with acute venous thromboembolism (VTE) found that there was no difference in recurrent VTE or VTE-related mortality if they received...
New Orleans—A prespecified subgroup analysis of 2 randomized, phase 3 trials that included patients with acute venous thromboembolism (VTE) found that there was no difference in recurrent VTE or VTE-related mortality if they received...
New Orleans—A prespecified...
02/19/2014
First Report Managed Care
News
Found: Doctors Who Take Medicare
07/08/2011
07/08/2011
First Report Managed Care
News
Medicaid Expansion Causing “Red” States to Rethink ACA?
09/26/2014
According to a recent report, up to a dozen states, including several led by Republicans, could move forward with plans to expand coverage under Medicaid after the November elections. This follows Pennsylvania and other states that have won...
According to a recent report, up to a dozen states, including several led by Republicans, could move forward with plans to expand coverage under Medicaid after the November elections. This follows Pennsylvania and other states that have won...
According to a recent report, up...
09/26/2014
First Report Managed Care

Video Insights

Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care
Farrukh Awan, MD
Videos
Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia
08/14/2024
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights...
08/14/2024
Journal of Clinical Pathways
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

May 2016 Volume 13 Issue 5

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement